Blood Screening Market By Product & Service, By Technology, By End User, Geography and Forecast – 2019 to 2024

(1 customer review)

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: February 6, 2020
Clear
SKU: GMS701-1-1 Category:

The blood screening market is expected to reach USD 3.32 billion by 2024, rising over the forecast period at a CAGR of 8.66%. The growing demand for donated blood, the increasing number of blood donations, the increasing prevalence of infectious diseases, and the increasing prevalence of new pathogens are driving this market’s growth.

Blood Screening Market By Product & Service, By Technology, By End User, Geography and Forecast - 2019 to 2024 1

Blood Screening Market By Product & Service, By Technology, By End User, Geography and Forecast - 2019 to 2024 2

Blood Screening Market By Product & Service, By Technology, By End User, Geography and Forecast - 2019 to 2024 3

Blood Screening Market By Product & Service, By Technology, By End User, Geography and Forecast - 2019 to 2024 4

Blood Screening Market By Product & Service, By Technology, By End User, Geography and Forecast - 2019 to 2024 5

Blood Screening Market By Product & Service, By Technology, By End User, Geography and Forecast - 2019 to 2024 6

Blood Screening Market By Product & Service, By Technology, By End User, Geography and Forecast - 2019 to 2024 7

Blood Screening Market By Product & Service, By Technology, By End User, Geography and Forecast - 2019 to 2024 8

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 SECONDARY SOURCES
2.1.2 PRIMARY DATA
2.1.2.1 PRIMARY SOURCES
2.1.2.2 BREAKDOWN OF PRIMARIES

2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.2.3 MARKET SHARE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.2.4 CHALLENGES

5 INDUSTRY TRENDS
5.1 INTRODUCTION
5.2 VALUE CHAIN

6 BLOOD SCREENING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 Reagents and Kits
6.3 NAT Reagents and Kits
6.4 ELISA Reagents and Kits
6.5 Others

7 BLOOD SCREENING MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 Transcription-Mediated Amplification
7.3 Real-time Polymerase Chain Reaction
7.4 Fluorescent immunoassay
7.5 Rapid Tests
7.6 Western Blot Assays
7.7 Other

8 BLOOD SCREENING MARKET, BY END USER
8.1 INTRODUCTION
8.2 Blood Banks
8.3 Hospitals

9 GEOGRAPHIC ANALYSIS
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 UK
9.2.4 GERMANY
9.2.5 FRANCE

9.2.6 ITALY
9.2.7 REST OF EUROPE
9.3 ASIA PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 SOUTH KOREA
9.4.4 INDIA
9.4.5 REST OF APAC
9.5 REST OF THE WORLD (ROW)
9.5.1 MIDDLE EAST
9.5.2 SOUTH AMERICA
9.5.3 AFRICA

10 MARKET ENTROPY
10.1 NEW PRODUCT LAUNCHES
10.2 M&A’s, COLLABORATIONS, JVs, AND PARTNERSHIPS

11 COMPANY PROFILES
11.1 INTRODUCTION
(Business overview, Products offered, Recent developments)*
11.2 KEY PLAYERS
11.2.1 F. Hoffmann-La Roche
11.2.2 GE Healthcare
11.2.3 Becton, Dickson and Company
11.2.4 Danaher Corporation
11.2.5 Abbott Laboratories
11.2.6 Siemens Healthineers
11.2.7 Biomérieux
11.2.8 Bio-Rad Laboratories
11.2.9 Ortho Clinical Diagnostics
11.2.10 Thermo Fisher Scientific
11.2.11 Company 11 & More
*Details on Business overview, Products offered, Recent developments might not be captured in case of unlisted companies.

12 APPENDIX
12.1 SOURCES
12.2 ABBREVIATIONS